News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
285 Results
Type
Article (110)
Company Profile (1)
Press Release (174)
Section
Business (70)
Deals (8)
Drug Development (112)
FDA (15)
Job Trends (7)
News (173)
Policy (40)
Tag
Academia (5)
Alliances (5)
ALS (21)
Alzheimer's disease (11)
Antibody-drug conjugate (ADC) (1)
Approvals (13)
Bankruptcy (1)
Best Places to Work (4)
Biotechnology (1)
Cancer (2)
Cell therapy (1)
Clinical research (77)
Collaboration (1)
COVID-19 (8)
C-suite (1)
Data (2)
Depression (1)
Diabetes (1)
Diagnostics (1)
Drug discovery (1)
Duchenne muscular dystrophy (1)
Earnings (24)
Editorial (2)
Events (43)
Executive appointments (1)
FDA (15)
GLP-1 (5)
Government (2)
Healthcare (2)
Huntington's disease (2)
Infectious disease (8)
IPO (6)
Job creations (2)
Layoffs (2)
Legal (1)
Lung cancer (1)
Mergers & acquisitions (3)
Metabolic disorders (1)
Neurodegenerative disease (5)
Neuropsychiatric disorders (1)
Neuroscience (31)
NextGen: Class of 2025 (6)
Non-profit (6)
Obesity (1)
Opinion (3)
Parkinson's disease (1)
People (40)
Phase I (13)
Phase II (52)
Phase III (42)
Pipeline (2)
Preclinical (3)
Rare diseases (2)
Regulatory (40)
Research institute (4)
Schizophrenia (3)
Special edition (1)
Startups (2)
The Weekly (1)
Weight loss (1)
Date
Today (1)
Last 7 days (3)
Last 30 days (5)
Last 365 days (46)
2025 (20)
2024 (54)
2023 (45)
2022 (83)
2021 (41)
2020 (24)
2019 (9)
2018 (1)
2017 (4)
2016 (3)
2015 (1)
Location
Asia (8)
Australia (2)
California (1)
Canada (1)
Connecticut (1)
Europe (17)
Massachusetts (32)
New York (1)
Northern California (1)
Ohio (1)
United States (36)
285 Results for "amylyx".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Regulatory
FDA Presses Pause on Atara’s Programs, Play on Amylyx’s ALS Assets
The FDA is putting Atara’s active Investigational New Drug applications on hold due to manufacturing concerns at a third-party provider while releasing Amylyx’s investigational ALS therapy from a previous pause.
January 22, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Amylyx Pharmaceuticals to Participate in Upcoming May Investor Conferences
May 7, 2025
·
1 min read
Press Releases
Amylyx Pharmaceuticals Reports First Quarter 2025 Financial Results
May 9, 2025
·
15 min read
Press Releases
Amylyx Pharmaceuticals to Report First Quarter 2025 Financial Results on May 8, 2025
May 1, 2025
·
1 min read
Press Releases
Amylyx Pharmaceuticals to Present at the 24th Annual Needham Virtual Healthcare Conference
April 2, 2025
·
1 min read
Press Releases
Amylyx Pharmaceuticals Announces First Participant Dosed in Pivotal Phase 3 LUCIDITY Trial of Avexitide in Post-Bariatric Hypoglycemia
April 30, 2025
·
8 min read
Press Releases
Amylyx Pharmaceuticals Announces Positive Long-Term Results from Phase 2 HELIOS Clinical Trial of AMX0035 in People with Wolfram Syndrome
May 12, 2025
·
9 min read
Press Releases
Amylyx Pharmaceuticals to Participate in Upcoming March 2025 Investor Conferences
February 26, 2025
·
1 min read
Deals
Amylyx Rebuilds Momentum Following Relyvrio Market Withdrawal
While supportive of Amylyx’s acquisition of a GLP-1 drug, analysts say the company’s future hinges on key upcoming readouts from multiple products in its pipeline.
July 24, 2024
·
5 min read
·
Heather McKenzie
Press Releases
Amylyx Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results
March 4, 2025
·
15 min read
1 of 29
Next
